Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)

Volker Möbus, Hans‐Joachim Lück, Ekkehart Ladda, Peter Klare, Marcus Schmidt, Andreas Schneeweiß, Eva‐Maria Grischke, Grischa Wachsmann, Helmut Forstbauer, Michael Untch, Frederik Marmé, Jens‐Uwe Blohmer, Christian Jackisch, Jens Huober, Elmar Stickeler, Mattea Reinisch, Theresa Link, Bruno V. Sinn, Wolfgang Janni, Carsten Denkert, Jenny Furlanetto, Knut Engels, Christine Solbach, Sabine Schmatloch, Julia Rey, Nicole Burchardi, Sibylle Loibl